| Bid Price | 6.50p | High Price | 6.73p |
|---|
| Ask Price | 7.00p | Low Price | 6.73p |
|---|
| Open Price | 6.75p | Spread | 7.14% |
|---|
| Prev Close | 6.75p | Volume | 31,500 |
|---|
Ondine Biomedical Inc. Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| May 17, 2024 | 6.75 | 6.73 | 6.73 | 6.75 | 31,500 |
| May 16, 2024 | 6.60 | 7.00 | 6.50 | 6.75 | 296,709 |
| May 15, 2024 | 6.60 | 6.70 | 6.50 | 6.60 | 10,612 |
| May 14, 2024 | 6.60 | 6.70 | 6.65 | 6.60 | 100,500 |
| May 13, 2024 | 6.75 | 7.00 | 6.50 | 6.60 | 343,153 |
Ondine Biomedical Inc. Information
| Name | Ondine Biomedical Inc. | Index | FTSE AIM All Share |
|---|
| ISIN | CA68234M2058 | Epic | OBI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Closed |
|---|
| Shares in Issue | 277.29 m | Prev Close | 6.75p |
|---|
| PE Ratio | | Market Cap | £18.72 m |
|---|
| Div Yield | 0 | Div per Share | NaN CAD |
|---|
| EPS | -0.04 CAD | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.928395 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.341758 | Quick Ratio | 1.711052 |
|---|
Ondine Biomedical Inc. Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 03/05/24 | PLAC | Craig Tooman | NED | 446,402 @ £0.07 | £31,248.00 |
| 03/05/24 | PLAC | Carolyn Cross | CEO | 1,825,650 @ £0.07 | £127,796.00 |
| 03/05/24 | PLAC | Junaid Bajwa | NED | 491,042 @ £0.07 | £34,373.00 |
| 03/05/24 | PLAC | Jean Duvall | NED | 535,683 @ £0.07 | £37,498.00 |
| 03/05/24 | PLAC | Simon Sinclair | NED | 558,003 @ £0.07 | £39,060.00 |
Ondine Biomedical Inc. News
